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Peer injecting: implications for injecting order and
blood-borne viruses among men and women who inject
heroin
KARENMCELRATH & JULIE HARRIS
School of Sociology, Social Policy & Social Work, Queen’s University, Belfast, Northern Ireland
Abstract
A large body of research has highlighted practices and rituals that characterise injecting drug use and
behavioural and environmental risks that can contribute to the transmission of blood-borne viruses.
Compared with other injecting practices, considerably less is known about peer injecting, i.e. receiving
or giving injections, particularly the social context in which it occurs. In this article, we explore peer
injecting and injecting order at initiation into injecting drug user (IDU) and during subsequent injection
episodes. Using data from semi-structured interviews, we highlight the experiences of 41 males and
females who had received injections from other IDUs. Respondents were recruited through various
strategies, largely chain referral. The results suggest gendered similarities as well as differences in terms
of peer injecting, the order of injection and micro-risk contexts for blood-borne viruses.
Keywords: Gender, injecting drug use, injecting order, assisted injection, peer injecting
Introduction
Considerable research has described behaviours among injecting drug users (IDUs) that can
pose risk for hepatitisC andHIV infection.These behaviours include the loaning andborrowing
of injecting equipment (Chitwood et al., 2000;Hagan et al., 2001;De et al., 2007), frontloading
and backloading (Grund et al., 1991; Jose et al., 1993; Stark et al., 1996), booting/flushing and
other needle/syringe rituals (Pates et al., 2001;McElrath, 2006; Paintsil et al., 2010). IDUoften
occurs within dyads or small groups, micro-environments that can heighten the risk for blood-
borne viruses because of a greater likelihood of blood-to-blood among dyad or groupmembers.
In this article, we focus on another injecting practice in which IDUs often engage, i.e. peer
injecting, which we define as receiving injections from or giving injections to another IDU.
Peer injecting
The injecting process is generally more complicated than other routes of administering drugs;
thus, individuals are usually taught how to inject by more experienced injectors. Indeed, the
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first injection is rarely self-administered, which means that the process is facilitated by others
and therefore occurs within a socially interactive context (Bryant &Treloar, 2007; Frajzyngier
et al., 2007; Harocopos et al., 2009; Rhodes et al., 2011). While there is a growing body of
research into first injection, scholars have noted that this literature is largely epidemiological
(Sánchez et al., 2006).
Following initiation into IDU or the early stage of the injecting career, many individuals
begin to self-inject. However, some individuals never learn how to self-inject or never feel
comfortable injecting themselves. Others cannot self-inject because of withdrawal symptoms,
venous or other health problems (Carlson, 2000; Wood et al., 2003; Fairbairn et al., 2010)
and may consistently or periodically rely on other individuals to inject them. Thus, receiving
injections from others can occur among IDU initiates, novices as well as long-term users.
This practice has been described as “injection assistance” (Robertson et al., 2010), “assisted
injection/injecting” (Wand et al., 2009; Fairbairn et al., 2010; Lloyd-Smith et al., 2010),
“requiring help injecting” (Wood et al., 2003; O’Connell et al., 2005), “receiving help
injecting” (Robertson et al., 2010) and “peer injecting” (Wright et al., 2007). The extent of
receiving injections is not well known; however, two studies found that approximately one-
quarter of IDUs reported seeking assistance with injecting (Robertson et al., 2010) or
providing assistance with injections during the 6-month period prior to interview (Fairbairn
et al., 2006). A third study found that 41.3% of IDUs had required help with injecting during
the past 6 months (O’Connell et al., 2005). The measures used in these studies were likely to
capture receiving and giving injections, as well as other kinds of injecting assistance.
Receiving help with injecting has been found to contribute to the transmission of hepatitis
C virus (HCV) (Wand et al., 2009) and HIV (O’Connell et al., 2005). The practice can
increase the likelihood of blood-to-blood contact not only through contaminated injecting
equipment but also through physical contact during the giving and receiving of injections
(Carruthers, 2003). Some injectors have reported accidental “sharing” of syringes while
receiving injections (Fairbairn et al., 2010), and peer injectors have been found to be
significantly more likely than other IDUs to loan needles/syringes, binge inject and attend
shooting galleries (Fairbairn et al., 2006), and behaviours that have been identified as factors
that contribute to blood-borne viruses (Shah et al., 1996; Miller et al., 2006).
Receiving injections from other IDUs can occur in different contexts and appear to vary in
terms of the social distance between the recipient and provider of injections. For example, the
recipient and the peer injector may be loosely connected through injecting networks, whereby
recipients of injection offer money or drugs in exchange for being injected. These providers of
injections have been described as “hit doctors”1 (Fairbairn et al., 2010) or “injection doctors”
(Carlson, 2000) who are sought out because they are perceived to have injecting expertise
(Carlson, 2000; Robertson et al., 2010). The social role of hit doctor can be embedded within
drug scenes and attached to particular settings, e.g. shooting galleries (Friedman et al., 2002),
and hit doctors are used extensively in some locales. For example, a respondent in Carlson’s
(2000) ethnographic study reported injecting between 8 and 15 people daily in exchange for
cash and a place to inject. Khan et al. (2009) identified 34 urban and rural injecting locations
in Sargodha, Pakistan, where two or three street injectors provided daily injections to 15–16
people. The heavy reliance on street injectors in that study was linked to wider drug
market factors, e.g. high-purity heroin, drug trafficking routes, as well as individual factors,
e.g. relative inexperience with injecting among the majority of the sample.
Alternatively, the recipient and provider of injections can be friends who are members of
the same social network whereby the peer injector may or may not be reimbursed with cash or
drugs. In other contexts, the two individuals are partners or significant others who have an
32 K. McElrath & J. Harris
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intimate relationship that was established prior to injection initiation or during the injecting
career. Studies have described the importance of gender and gendered dynamics that char-
acterise initiation into IDU. For example, some research has found that females andmales are
likely to be injected by males at initiation (Kermode et al., 2007). Although earlier research
found that women tend to be first injected by a (male) sex partner (Crofts et al., 1996;
Sherman et al., 2002), the relationship between female initiates and peer injectors has been
found to differ across geographic areas (Tompkins et al., 2005), with an increasing number of
reports highlighting women’s role in initiating other women into IDU (Doherty et al., 2000;
Bryant & Treloar, 2007).
Other research has focused on gender and receiving injections among IDUs with rela-
tively long injecting histories. For example, studies have shown that females are significantly
more likely than males to require help with injecting or to engage in assisted injecting
(Wood et al., 2003; O’Connell et al., 2005; Wand et al., 2009; Robertson et al., 2010).
These gender differences might result from unequal power relationships that can charac-
terise the social context of injecting, venous differences between men and women (Kral
et al., 1999), frequency of receiving or giving injections (Wand et al., 2009) and/or disparate
knowledge of the injecting process (Treloar et al., 2003; Wood et al., 2003). Although the
previous research tends to suggest that females are more likely than males to require help
with injecting, findings from a social epidemiological study suggest that males and females
were equally likely to provide injections during the 6months prior to the interview (Fairbairn
et al., 2006).
Peer injecting and the order of injecting
The setting that characterises peer injecting involves a minimum of two people, and the
person who injects another IDU might also self-inject in the same setting. This kind of peer
injecting suggests that injecting is ordered, i.e. one injection follows and precedes another.
Peer injectors who inject first can pass on blood particles to the recipient of injection who is
injected second. If the peer injector injects second, the blood spill from the recipient of
injection can be passed on to the peer injector. Thus, the order of injecting in these settings
can further escalate the risk for transmission of blood-borne viruses. This risk is intensified
when the same injecting equipment (e.g. needle, syringe, filter, cooker, water and tourniquet)
is used, but can also occur through other blood-to-blood contact that occurs during injections
that are given or received by another.
Research that focuses on the order of injecting suggests a complex picture whereby inject-
ing order appears to vary over the injecting career and across injecting settings. At initiation,
women IDUs have been reported of being injected by an IDU after she/he self-injects
(Tompkins et al., 2005), although the same injecting order might also occur among male
initiates. As IDUs progress through an injecting career, the order of injecting appears to be
affected by multiple factors and can change depending on the social context as well as the
“capital” that IDUs bring to the scene (Crisp et al., 1997, 1998). In general, Crisp et al.
(1997) found that the first injection was reserved for the individual who possessed or owned
the needle/syringe, particularly when they also had purchased the drugs (see also Tompkins
et al., 2005). In a few instances, individual factors (e.g. assertiveness, aggressiveness, knowing
and sharing whether a group member was HIV antibody positive) affected injecting order
even when individuals did not possess needles/syringes or purchase the drugs. The authors
found that gender had no consistent effect on the order of injecting; females injected first in
some settings (males being chivalrous) and second in other settings (females as subordinate).
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Both contexts are linked to traditional gender norms and gender role expectations. Crisp et al.
(1997, p. 283) did not report extensively on the link between peer injecting and order of
injecting but noted that that majority of the 32 respondents reported that peer injectors
tended to inject first. A second qualitative study was conducted in England and focused on
the experiences of 45 female IDUs in contact with drug or health services (Tompkins et al.,
2005, 2006). Those authors suggested that injecting order also is affected by a range of
situational and contextual factors, including the severity of withdrawal, the level of intoxica-
tion of the injector, inexperience of the person being injected and the nature of social and
sexual relationships among the persons present.
Aims of the study
Peer injecting appears to be a relatively common practice at initiation and at various stages of
the injecting career. When peer injectors self-inject within the same setting, the practice is
likely to necessitate a particular injecting order that can escalate risk for blood-borne viruses.
The purpose of this study is to explore the context of receiving injections from other IDUs at
initiation and during subsequent stages of the injecting career. We also address the order of
injecting as it relates to IDUs who are peer injected. We focus on the experiences of male and
female IDUs in order to explore the role of gender differences and gendered dynamics as they
relate to these practices.
Background
The available public health and police indicators suggest that problem heroin use and
injecting began to surface in Northern Ireland during the mid-1990s to late 1990s,
relatively later than other western European countries. Although data are not widely
available from earlier decades, indicators suggest that individuals experiencing heroin
dependence rarely came to the attention of medical professionals or treatment services
during the 1970s and 1980s (Murray, 1994). The large-scale presence of police and British
army, frequent stops and searches and some of the most sophisticated surveillance systems
in Europe would have probably uncovered a heroin market that had once existed
(McElrath, 2004). Problem heroin use and IDU began to surface during the mid-1990s
to late 1990s, coinciding with the progress towards peace in Northern Ireland (McElrath,
2004). In 2001, the number of problem heroin users was estimated to be 828 (95% CI:
695–1018) (McElrath, 2002). Hay et al. (2006) found an estimated 1395 opiate users
(including problem heroin users) in Northern Ireland during 2004, but substantially
lower prevalence rates compared to England, Scotland and the south of Ireland.
Pharmacy-based needle/syringe exchange schemes were introduced in Northern Ireland
during 2001, and substitute prescribing (methadone and high-dose buprenorphine)
became available in 2004.
The study site was the Eastern Health and Social Services Board (EHSSB) area, a geo-
graphic area that includes Belfast, the largest city in Northern Ireland. Near the time of the
study, EHSSB claimed the largest estimated number of opiate users in Northern Ireland
(1.68 per 1000 people aged 15–64 years) (Hay et al., 2006), as well as the largest number of
individuals registered by medical professionals in the region’s register of “addicts”
(Department of Health, Social Services & Public Safety, 2011). Qualitative research into
IDU in Northern Ireland previously found that IDU respondents in this health board area
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had injected more frequently, were more likely to inject stimulants, had longer histories of
injecting, knew substantially more IDUs with hepatitis C infection and were less likely to be
engaged with treatment services compared to IDUs in other health and social service board
areas (McElrath & Jordan, 2005).
Method
Data presented in this article are a subset from a larger study that focuses on gender, risk
environments and transitions to injecting among 54 adult men and women (Harris, forth-
coming). All respondents had injected illicit drugs (namely heroin), or had smoked or sniffed
heroin within 4 weeks prior to the interview. Data were collected between 2008 and 2010,
primarily within the Belfast region. In this article, we focus on the subset of respondents who
had received injections from another IDU (N ¼ 41), either during initiation or subsequently
during the injecting career.
Multiple recruitment strategies were used in an attempt to include a range of respondents
with diverse drug histories and different socio-demographic backgrounds. Sample character-
istics were monitored frequently and targeted sampling was introduced when particular types
of respondents appeared to be under-represented. The study was advertised in hostels, three
pharmacy-based needle/syringe exchange schemes and via professional and personal con-
tacts. Snowballing sampling was also utilised and attracted the highest number of respon-
dents with 15 chains established. Drug outreach workers also helped with recruitment, which
resulted in the participation of five other respondents.
Data were collected through semi-structured interviews that focused on initiation into
heroin use and injecting, patterns of use, transitions in and out of injecting and social contexts
of use. Interviews were digitally recorded, lasted between 60 and 150 minutes and were
conducted by the second author. Interviews were conducted in private settings, including
university offices, drug outreach premises and in a local hostel. Considerable time was taken
to establish rapport with respondents before, during and after each interview. Experiences
were shared and interviewer’s self-disclosure was utilised when necessary. Each participant
was reimbursed £20 as an acknowledgement of their time and travel expenses to/from the
interview, and the second author transcribed the interview data. Ethical approval was
obtained from four bodies: (1) Research Ethics Committee, School of Sociology, Social
Policy and Social Work, Queen’s University, (2) Research Governance, Queen’s
University, (3) the Belfast Health Trust, and (4) the Office for Research Ethics for
Northern Ireland. Strict ethical protocols were followed. Respondents were provided with
information about the study and time was taken to fully explain the purposes of the research.
Written consent was obtained prior to the interview and assurances were provided in regard to
anonymity and confidentiality.
Analysis
The analytical approach commenced with several reads of the interview transcripts, noting
emerging themes and categories, and developing coding schemes. Preliminary patterns
relating to peer injecting and order of injecting were analysed, followed by a system of
corroboration and comparison with other cases. The thematic framework was refined by
searching the interview data for variations in peer injecting experience. Segments of text were
tagged and integrated under the core themes and then refined further into sub-themes,
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e.g. gender and gendered contexts. We explored dominant patterns, socio-environmental
conditions where patterns remained as well as outliers.
Member validation was provided to respondents who were provided the opportunity to
read their interview transcript and review selected analytical findings. This form of validation
appeared to further enhance rapport and, in turn, helped to improve the credibility and
validity of the research by ensuring that the findings presented a relevant and acceptable
interpretation of the respondents’ experiences (Karnieli-Miller et al., 2009).
Results
Approximately three-quarters of the sample (N ¼ 41) reported receiving injections from
another IDU.2 This sub-sample included 14 females and 27 males, whose ages ranged from
20 to 54 years (mean¼ 33;median¼ 31). The average age of initiation into IDUwas 20 years,
with a range of 15–33 years. The duration of injecting spanned from 1 month to 25 years.
Initiation
Themajority ofmale and female respondents were injected bymales at initiation, and females
were more likely than males to be injected by a partner (females ¼ 50%; males ¼ 11%). Nine
male and female respondents were first injected by females, and respondents’ reports sug-
gested that female peer injectors had considerable experience with injecting and were well-
connected to drug networks. Both males and females recalled their lack of injecting knowl-
edge at initiation:
She [partner] had called round to my house and she got me quite a wee bit of it [heroin]
and she done the business. She prepared it and everything and then she injected me with it.
So that was basically my first time and then she had given me the rest of it of what she had
got for me but I wasn’t aware of getting needles or anything and all the rest of it [other
injecting equipment, the injecting process], so I didn’t really know what to do with the rest
of the stuff then. (Male, late 20s)
Three respondents were first injected by male or female family members whose injecting
histories tended to normalise injecting for these respondents. A female recalled being injected
first by her mother who reportedly tried to “help” when her daughter experienced trauma:
Well I was 16 years of age and I got pregnant at 15 and then I lost the baby at 16 and my
Mum was an addict so the best way for my Ma to try and help me was to give me an
injection of heroin. (Female, mid-20s)
In contrast with previous research that highlighted the role of “dominant [male] partners”
(Tompkins et al., 2005, p. 27) or persuasion by others to initiate IDU (Frajzyngier et al.,
2007), we found little evidence of respondents being coerced or persuaded into injection,
even when they had smoked heroin for lengthy periods of time. Indeed, respondents recalled
how some peer injectors were reluctant to inject them (see also Rhodes et al., 2011) and
several females as well as males noted how they talked to other IDUs into injecting them.
Reluctance on the part of the peer injector appeared to be influenced by peers’ interest in
trying to protect would-be initiatives from stigmatised identities and the health risks
36 K. McElrath & J. Harris
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associated with injecting. However, most male and female respondents were proactive,
demonstrating agency in their quest to be injected:
She didn’t really want me to doing it, but I talked her into doing it. (Male, early 40s)
I eventually talked someone into it. No one wanted to do it for me [and] I didn’t know how
to inject myself at the time. But I eventually talked someone into doing it, who I think to
this day, the person still feels guilt-ridden about it. But again it was my choice at the end of
it. (Female, early 30s)
Only one respondent in this study described an initiation scenario that might be described as
being influenced by coercion or persuasion from others. He recalled how he was encouraged
to inject by his female partner and another male who was present at the scene:
It [injecting] came from basically pressure from the person [partner] who I was with, they
wanted me to inject and I didn’t want to inject. I was quite happy to smoke it. There was
three of us and she [partner] was like, ‘Come on and inject it’ and he was like, ‘Yeah, come
on and we’ll try it’. And I was like, ‘Nah man, I don’t want to’ and then the next thing was
that it was there and it was happening and that’s how it sort of happened. (Male, early 30s)
The majority of respondents (28 out of 41) reported injecting before the peer injector at
initiation. Of the 14 females who were injected by another IDU at initiation, approximately
half (8 out of 14) reported that they were injected first, that is, before the peer injector. In
contrast, three-quarters of males (20 out of 27) reported being injected first during initiation.
These results suggest that the relationship between the initiate and the peer injector helped
shape injecting order. Specifically, female initiates tended to inject second when the peer
injector was a partner, largely because of their intimate relationship with the peer injectors.
Continuation of peer injecting
The majority of respondents (31 out of 41) continued to be injected by another IDU as they
progressed through the injecting career. In general, however, respondents tended to vacillate
between self-injecting and receiving injections from others. Although the majority of female
respondents (11 out of 14) reported self-injecting within 6 months of initiation, they also
received injections from other IDUs:
You see trying to rely on other people to get the drugs as well and then relying on other
people to do it? I learnt pretty quickly how to inject myself. But in saying that there, my
veins now . . . I’ve been doing it [injecting] for about ten years now and my veins are
bolluxed [damaged, ruined] now. Absolutely bolluxed. (Female, early 30s)
A number of males also continued to receive injections from another IDU; however, all but
one male learned to self-inject within 6 months of initiation. Moreover, approximately one-
third of males self-injected during the second injection episode, whereas only 2 of 14 females
reported self-injecting during the next injecting session.
Following initiation, respondents noted that they continued to rely on males (partners,
acquaintances or friends) to inject them; however, some respondents relied on or preferred
female peer injectors. Respondents recalled using more than one peer injector during the
same setting:
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We were all in a squat and it was just when I got out of prison. We all shot in there and we
had two spoons there. I got [male friend] to dome. She [female friend] couldn’t find a vein.
She used to do everybody . . . and was just looking for a vein but couldn’t find one. She was
going mental [and] was going at it for about an hour. [Male friend eventually] found the
vein. (Female, early 30s)
Similar to previous research findings, data from this study suggest that withdrawal symptoms
and venous problems were the primary reasons for most subsequent peer injections. This
pattern held for both male and female respondents:
Nah, they [male friends/acquaintances] had their hit first. They always had to get their gear
into them first. You had to wait. You were the second person because you didn’t know how
to bang up [inject]. You were standing there with your needle waiting for them to hit you
up. (Male, early 30s)
I used to keep mine [drugs] in a wee tin pencil case and a couple of needles and citric and
you’re wee things of water. I would keep it all in the thing . . . But all the time somebody
would have to hit me up, ‘cause I’ve never went myself [never self-injected]. Well I’ve went
myself when I started you know when my veins, you could see them. But my veins only
lasted about six months. That was it, they were gone.Where as well I didn’t knowwhat I was
doing it, I was just sticking it everywhere so I was. Didn’t knowwhere I was going and once I
actually put it in here [points to arm]. Then after that I started getting afraid to hit up, so then
I was asking other people to do it for me and it was flipping going in my wrists, everywhere.
I’ve still got the scars [shows scars on wrists and arms]. (Female, late 30s)
Although most respondents reported being careful about their choice of peer injector,
respondents who were experiencing withdrawal or in the company of less experienced peer
injectors often were less selective. In some instances, claims about cautiousness were not
substantiated by partners who were present during some interviews:
R1: I’m very meticulous about the people who inject me. I wouldn’t just let anybody do it.
(Male, early 30s)
R2: Well that’s not really true. If you were sick it would be whoever. (Female partner,
early 30s)
R1: No, if I was sick I would go to a certain person who I know would do it for me.
R2: That would be for the last ten years because you haven’t been able to inject yourself.
[He’s] always had to buy two bags.
R1: One for them [the peer injector] and one forme . . . I would get the stuff [heroin] and I
would make a phone call to the two or three people who I knew, that I could trust and
go to them. One of themwas like a heroin addict then, so the chances of him saying no
to you were slim to none. So I had three trusted people who I know I could phone and
at least one of them would definitely say, ‘Yes, come on round’. . . My veins are in
good condition because other people do it for me. They take more care, whereas if
you’re doing it yourself you could hurt yourself more.
The data show that injecting order fluctuated among males and females during subsequent
peer injections. That is, when asked about injecting order during subsequent peer injections,
most respondents (21 out of 31) reported that they “sometimes” were the first to be injected
38 K. McElrath & J. Harris
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during these episodes. Injecting order was influenced by multiple micro- and macrolevel
factors, including the availability of heroin:
They [male friends/acquaintances] just wanted the hit first. I mean in [place in NI], there
wouldmaybe be times [. . .] when youwould have to wait three days [for heroin]. Four days
for some of it, you know? Evenwaiting longer than that andwhen you’re waiting that length
of time, whenever you do get some, you don’t want to be bothered doing somebody else
you know? You want to do your own first. (Male, mid-40s)
Both male and female respondents demonstrated some degree of power and control over the
injecting order. Their degree of influence depended on their relationship with other IDUs in
the setting, as well as which party bought or owned the drugs. These factors often took
precedent over an injector’s withdrawal symptoms:
He [partner] just couldn’t wait [withdrawal] and I’m going like, ‘Now hold on a second, I
don’t want to bring this to account, but I bought it. It’s my money and I want to hit up first
before you get so out of it and you miss’. And I said ‘No, if I buy it then I get to hit up first’,
and I always did buy it. (Female, late 30s)
Females who were injected by partners recalled “going second,” because partners were
experiencing withdrawal symptoms. A few female respondents questioned male partners’
justifications for insisting on injecting first:
I: So it was really to stop him from withdrawal?
R: Yeah, something to stop him shaking so that he would be steady with me. That’s what
he said and I could sort of understand, and it was true some of the time, but it wasn’t
true all of the time. He just couldn’t wait. (Female, late 30s)
The majority of females and about half the males reported paying an IDU to inject them, and
payment was nearly always made with drugs as opposed to cash. Males were more likely than
females to report never having to provide cash or drugs in exchange for being injected. A
female respondent who reported always being injected by other IDUs described an exchange:
You would have had to give them a bit in the needle, yeah. They would have been like,
‘What are you going to give me out of it?’And I would have just put a bit of powder out and
went, ‘Right, there. And that’s all I’ve got.’ But money? No. (Female, early 30s)
At times, however, peer injectors had considerable access to drugs and did not expect
compensation for peer injecting. This pattern was observed primarily among same-sex
friendships:
I: Did you have to give anything to the person injecting you?
R: Aye, like sort them out. Yeah, I would have had to give them about half a bag [of
heroin], depending on who it was. Just say they had their own [heroin]. . .Just say I used
to go round to mymate [female friend] but she sold it as well so she didn’t mind, know
what I mean? I would usually have given [female friend] a pipe or whatever, but she
didn’t care about a hit cause she had her own [heroin]. Or else I would have put a bit of
crack into her thing, and then she would have a snowball, you know mixing it? And we
would have done it that way.
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I: So it just depended on who you were with?
R: Yeah.
I: Aye, I can see that. Did you have to give anything to the person injecting you?
R: Aye, like sort them out. Yeah, I would have had to give them about half a bag. It
depending on who it was. Just say they had their own. Just say I used to go round to my
mate [female friend] but she sold it as well so she didn’t mind [injecting me], know
what I mean? I would usually have given [female friend] a pipe or whatever, but she
didn’t care about a hit cause she had her own. Or else I would have put a bit of crack
into her thing, and then she would have a snowball, you knowmixing it? And we would
have done it that way.
I: So it just depended on who you were with?
R: Yeah.
Although payment for being injected by an IDU was the norm in this sample, a few respon-
dents reported that they never or rarely paid for this service with either drugs or money.
A female reported that nearly all her injections were provided by other IDUs, and that her
peer injectors were always male who rarely asked for compensation. She described her
relationships with the peer injectors:
The first time it was my ex-partner. Second time it wasmy present boyfriend, and the other
two times it was men that I’d known for years but they had already come on to me anyway.
I knew that they wanted to be lovers with me on previous occasions but it never happened
but they did end up injecting me. (Female, late 30s)
She continued by describing the negotiation over clean needles/syringes during her quest to
be injected by a male IDU. In the excerpt below, she demonstrates control over the exchange
with the male peer injector:
Like if they said to me, ‘Give us that needle after you’, and I says, ‘Nah, this is a clean
needle. You have hepatitis and I haven’t. I’ll only give you a run [bit of heroin].’ Or, ‘I’ll
give you £20 or I’ll give you a bag’. [They’d say] ‘Right, well then go on and giveme a bag if
you won’t giveme a needle.’ I could have four or five needles but I wasn’t going to be telling
them that.
Some respondents recalled the difficulties with coordination and dexterity among peer
injectors who self-injected first, and then began to experience the effects of heroin before
they injected the respondent. In these scenarios, peer injectors sometimes made several
attempts to inject the other person, missing veins during the attempts. A female reported
that male IDUs always injected before her, “They had to have it. They needed it.” The
interviewer asked whether the male peer injectors ever missed a vein, while attempting to
inject her:
Oh god yeah. You could even see somebody standing and they’d be gouching [nodding off
as a result of heroin use; intoxication]. Their eyes would be closed and then somebody
would come over and take over and even [my partner] at times, he’d be standing and you’d
think his legs were going to buckle underneath him. And then there’d be arguments around
hep C, and me going, ‘Make sure you use separate equipment’. And him saying, ‘But
I didn’t use that spoon’. And I’m going, ‘Well, that’s the only spoon that shape ‘cause
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I stole it out of [restaurant]’ and you’ve just used it and you’re using it with me again’”.
(Female, late 30s)
Previous research has also highlighted “gouching” among peer injectors who attempt to
administer injections to women (Tompkins et al., 2005). In this study, this experience
intensified risk scenarios, particularly when respondents used more than one peer injector:
I: Would the person that was injecting have gone first?
R: Aye, and I hated it because they were always like, ‘Eeow’, gouching and they sticking the
needle everywhere in my arm and I’m sitting going, ‘Fuck sake, I’m busting for a hit’.
And I had to say to them, ‘Would you open your eyes fuck’s sake?’ They were just like
really gouching out and I couldn’t do it [inject] myself, so it was so frustrating, so it was.
I: Did that vary in terms of who you were with? Like if you were with [female friend]
would she have done you first?
R: Aye, most of the time she would have done me first because she would have went
[injected] into her groin . . . But she would usually been always really gouched out on
gear [heroin]. I was never really one for gouching. I was always up, if you know what I
mean. I think that was because of the crack. I never ever felt gouched out, you know?
(Female, late 20s)
Discussion
The findings highlight the layers of risk associated with the peer injecting environment. These
layers of risk begin during initiation into IDU when respondents were administered an
injection by an IDU who also self-injected. Although the majority of respondents reported
that they injected first at initiation, 13 other respondents recalled injecting second, which
likely entails greater exposure to blood from the peer injector. Peer injecting commenced
becausemale and female initiates lacked knowledge about the injecting process. Although the
majority of respondents learned to self-inject within 6 months of initiating IDU, a few
individuals never felt confident with injecting, preferring other IDUs to provide injections
for them. For other respondents, peer injecting did not necessarily continue immediately after
initiation, rather, it re-surfaced when respondents developed venous problems or experi-
enced withdrawal symptoms that prevented self-injection.
Additional layers of risk were introduced because recipients of injecting utilised several
different peer injectors over the injecting career; similar to the various levels of skill among
professional phlebotomists, some peer injectors were perceived as better than others. A few
respondents recalled being exposed to more than one peer injector in the same injecting
setting. In these contexts, peer injectors’ incapability to administer injections appeared to
be affected by the pharmaceutical effects of heroin. Respondents spoke of peer injectors’
several attempts to administer injections. The physical scarring left by some attempts was
likely preceded by the presence of blood at the injecting sites. These findings suggest that
although peer injectors can introduce risk to injecting settings, they also can be dispropor-
tionately exposed to it. Risk environments were also created by peer injectors who experi-
enced withdrawal symptoms prior to injecting, and insisted on self-injecting prior to peer
injecting. Observing a peer injector undergo “dope sickness” created anxiety for respon-
dents who wished to inject first due to their own withdrawal effects or concerns over safety.
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Gender and peer injecting
We found similarities as well as gender differences at initiation. Most males and females
actively sought out IDUs to first inject them, despite the initial reluctance of other IDUs.
Additionally, most males and females were most likely to be peer injected by a male IDU;
however, roughly half of all females were first injected by a male partner, whereas only three
males (approximately 10% of male respondents) were injected by a female partner. Injecting
order tended to favour male respondents; however, heterosexual partners who were peer
injectors tended to inject first regardless of whether the recipient was male or female. The
relatively small number of study participants prevented us from further investigating this
pattern among male/female dyads.
Both male and female recipients of injection were affected by the well-being of the peer
injector and considered whether peer injectors experiencing withdrawal were more capable
than peer injectors who were intoxicated. Additionally, men and women recalled the
difficulties associated with frequent attempts to locate peer injectors, and relied on more
than one IDU to inject them. However, females were more likely than males to provide
drugs in exchange for being peer injected, particularly as they progressed through the
injecting career. Although some scholars might view this finding as evidence of a gendered
power imbalance, we view it as an example of female injectors’ attempt to assert control over
their injecting episodes. We suggest that these exchanges tended to influence women’s
place in the injecting order. Compensating the peer injector meant that women could better
justify their choice to inject first, thus diminishing some risk associated with the injecting
environment.
Bryant et al. (2010, p. 185) found that a number of female IDUs in their study could not be
described as “passive participants,” in relation to their drug lifestyle roles. Rather, the authors
noted that several females in partnerships with male IDUs were integrated with IDU net-
works, and solely or jointly involved in drug purchase and preparation for injection. A few
females in this study behaved passively or assumed stereotypical gender roles, e.g. expecting
to inject second, preferring a male peer injector. However, our findings are more consistent
with those of Bryant et al. (2010). As discussed above, several other females proactively
asserted themselves with regards to the informal rules around injecting order. Additionally,
many females voiced knowledge about some safer injecting practices and this knowledge was
considered as they negotiated with peer injectors. Most males and females in this study
continued to or subsequently relied on peer injectors not because they lacked knowledge
about injecting but because they developed venous problems, and women tended to experi-
ence venous problems more quickly than men.
The findings from this study add further weight to the assumption that injecting risk is
influenced greatly by social networks and the social context in which it occurs. Harm
reduction and prevention efforts that target the behaviours of individual IDUs are unlikely
to be effective because they often ignore the role of structural factors and social network
influences that contribute to individual behaviours (Neaigus et al., 1994; Rhodes, 2002).
Reducing risk around peer injecting requires peer interventions that can be integrated with
trusted street outreach workers.
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Notes
1. According to Fairbairn et al. (2010), “hit doctors”were initially described in the literature
by Murphy & Waldorf (1991) in their study of San Francisco shooting galleries.
2. The remainder had either always self-injected or had never transitioned from smoking
heroin to injecting.
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